Literature DB >> 2414404

Dose-dependency of MBP-induced demyelination in the guinea pig.

G R Moore, U Traugott, S H Stone, C S Raine.   

Abstract

The pathology of experimental allergic encephalomyelitis (EAE) induced by bovine myelin basic protein (MBP) has been examined in the guinea pig with a series of doses ranging from 37.5 micrograms to 600 micrograms. This was to investigate whether the previously demonstrated lack of demyelinative effect by MBP was dose-related. At all doses tested, MBP induced clinical disease. Inflammation was the major feature of lesions in all animals. However, no demyelination was seen when 75 micrograms MBP or less was given. At higher doses (150 micrograms upwards), MBP always induced intense inflammation but demyelination was encountered inconsistently. These observations support the contention that in addition to an immune response to MBP, other factors contribute to autoimmune demyelination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414404     DOI: 10.1016/0022-510x(85)90087-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Suppression of acute experimental allergic encephalomyelitis by synthetic serum thymic factor. Clinical, histopathological, and immunohistochemical studies.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Experimental allergic encephalomyelitis in guinea pig: variability of response to intradermal emulsion injection.

Authors:  D Gambi; N Di Cesare; G Di Trapani; G Macchi; A Sbriccoli
Journal:  Ital J Neurol Sci       Date:  1989-02

Review 3.  Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.

Authors:  V K Tuohy
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

4.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.

Authors:  Minodora O Totoiu; Gabriel I Nistor; Thomas E Lane; Hans S Keirstead
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.